Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000870709 | SCV001012241 | benign | Hereditary spastic paraplegia 54 | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847083 | SCV002104613 | likely benign | Hereditary spastic paraplegia | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002539090 | SCV003752607 | likely benign | Inborn genetic diseases | 2021-07-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003438521 | SCV004164627 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | DDHD2: BP4, BS2 |
Breakthrough Genomics, |
RCV003438521 | SCV005223397 | likely benign | not provided | criteria provided, single submitter | not provided |